Literature DB >> 15128293

Endovanilloids. Putative endogenous ligands of transient receptor potential vanilloid 1 channels.

Mario Van Der Stelt1, Vincenzo Di Marzo.   

Abstract

Endovanilloids are defined as endogenous ligands of the transient receptor potential vanilloid type 1 (TRPV1) protein, a nonselective cation channel that belongs to the large family of TRP ion channels, and is activated by the pungent ingredient of hot chilli peppers, capsaicin. TRPV1 is expressed in some nociceptor efferent neurons, where it acts as a molecular sensor of noxious heat and low pH. However, the presence of these channels in various regions of the central nervous system, where they are not likely to be targeted by these noxious stimuli, suggests the existence of endovanilloids. Three different classes of endogenous lipids have been found recently that can activate TRPV1, i.e. unsaturated N-acyldopamines, lipoxygenase products of arachidonic acid and the endocannabinoid anandamide with some of its congeners. To classify a molecule as an endovanilloid, the compound should be formed or released in an activity-dependent manner in sufficient amounts to evoke a TRPV1-mediated response by direct activation of the channel. To control TRPV1 signaling, endovanilloids should be inactivated within a short time-span. In this review, we will discuss, for each of the proposed endogenous ligands of TRPV1, their ability to act as endovanilloids in light of the criteria mentioned above.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15128293     DOI: 10.1111/j.1432-1033.2004.04081.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  105 in total

Review 1.  [The capsaicin receptor. "TRPing" transduction for painful stimuli].

Authors:  W Greffrath
Journal:  Schmerz       Date:  2006-06       Impact factor: 1.107

Review 2.  Sensing the air around us: the voltage-gated-like ion channel family.

Authors:  Dennis Kim; James N Baraniuk
Journal:  Curr Allergy Asthma Rep       Date:  2007-05       Impact factor: 4.806

Review 3.  TRPV1 (vanilloid receptor) in the urinary tract: expression, function and clinical applications.

Authors:  António Avelino; Francisco Cruz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-05-24       Impact factor: 3.000

4.  TRPV1 channels mediate long-term depression at synapses on hippocampal interneurons.

Authors:  Helen E Gibson; Jeffrey G Edwards; Rachel S Page; Matthew J Van Hook; Julie A Kauer
Journal:  Neuron       Date:  2008-03-13       Impact factor: 17.173

Review 5.  Neural regulation of mucosal function.

Authors:  James N Baraniuk
Journal:  Pulm Pharmacol Ther       Date:  2007-07-17       Impact factor: 3.410

6.  WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.

Authors:  David A Price; Alex A Martinez; Alexandre Seillier; Wouter Koek; Yolanda Acosta; Elizabeth Fernandez; Randy Strong; Beat Lutz; Giovanni Marsicano; James L Roberts; Andrea Giuffrida
Journal:  Eur J Neurosci       Date:  2009-05-21       Impact factor: 3.386

7.  Physiology and pharmacology of the vanilloid receptor.

Authors:  Angel Messeguer; Rosa Planells-Cases; Antonio Ferrer-Montiel
Journal:  Curr Neuropharmacol       Date:  2006-01       Impact factor: 7.363

Review 8.  Synthetic cannabinoids and potential reproductive consequences.

Authors:  Xiaofei Sun; Sudhansu K Dey
Journal:  Life Sci       Date:  2013-07-01       Impact factor: 5.037

9.  Complex functions of phosphatidylinositol 4,5-bisphosphate in regulation of TRPC5 cation channels.

Authors:  Mohamed Trebak; Loic Lemonnier; Wayne I DeHaven; Barbara J Wedel; Gary S Bird; James W Putney
Journal:  Pflugers Arch       Date:  2008-07-30       Impact factor: 3.657

10.  N-oleoyldopamine, a novel endogenous capsaicin-like lipid, protects the heart against ischemia-reperfusion injury via activation of TRPV1.

Authors:  Beihua Zhong; Donna H Wang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-06-20       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.